All the more reason to be investing more than a pittance in the development of rejuvenation biotechnologies. So very close to realization, yet widely ignored.

Actually, it seems crazy to me that the economic argument gets more play than the humanitarian argument. People, including the old, seem happy to consign the aged to suffering and death, but that aging and age-related disease impacts the economy gets a larger fraction of them up in arms.